With the analysis among 66,405 patents, we discovered top 475 key players by total patent application. Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., LG H&H Co., Ltd. are dominant in this area. They take 1.56% of the total patent filing.
Tokyo-to, Japan
Patent: 399
Tokyo-to, Japan
Patent: 329
Seoul, South Korea
Patent: 306
Osaka-fu, Japan
Patent: 273
New Jersey, United States
Patent: 270
Tokyo-to, Japan
Patent: 259
California, United States
Patent: 239
Osaka-fu, Japan
Patent: 238
Tianjin Shi, China
Patent: 234
Tokyo-to, Japan
Patent: 227
With the analysis among 577 patents, we discovered top 114 start-ups by total patent application. Intarcia Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, Volterra, Inc. are active in this area.
California, United States
Patent: 45
California, United States
Patent: 28
California, United States
Patent: 26
Shanghai Shi, China
Patent: 22
District of Columbia, United States
Patent: 19
Illinois, United States
Patent: 18
undefined undefined
Patent: 12
With the analysis among related 18,593 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Yonsei Industry-Academic Cooperation Foundation, Estetra SPRL, Taiho Pharmaceutical Co., Ltd. take 0.96% of patent filing during this period.
Luxembourg, Belgium
Patent: 54
Tokyo-to, Japan
Patent: 53
Tokyo-to, Japan
Patent: 48
Zhejiang Sheng, China
Patent: 48
Chongqing Shi, China
Patent: 44
Guangdong Sheng, China
Patent: 44
Jiangsu Sheng, China
Patent: 38
With the analysis among related 18,593 patents in last 5 years, we discover 138 new entrants. Chongqing Yuelong Biopharmaceutical Co., Ltd., Suzhou Zelgen Biopharmaceuticals Co., Ltd., GI Innovation, Inc. are the most active new entrants in this area.
Chongqing Shi, China
Patent: 44
Jiangsu Sheng, China
Patent: 29
Shanghai Shi, China
Patent: 27
Hubei Sheng, China
Patent: 27
Washington, United States
Patent: 25
Liaoning Sheng, China
Patent: 25
With the analysis among 18,908 patents, we discovered top 301 universities and scientific research institutions by total patent application. Zhejiang University, China Pharmaceutical University, Guangxi University are dominant in this area. They take 6.51% of the total patent filing.
Zhejiang Sheng, China
Patent: 194
Jiangsu Sheng, China
Patent: 138
Guangxi Zhuangzu Zizhiqu, China
Patent: 135
Liaoning Sheng, China
Patent: 132
Jilin Sheng, China
Patent: 120
Shanghai Shi, China
Patent: 116
Shanghai Shi, China
Patent: 115
Guangdong Sheng, China
Patent: 103
Jiangsu Sheng, China
Patent: 102